The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•15 June 2026•

2 min read

Mixed US Mid-Cap Earnings as RF Industries Beats and Dave & Buster's Misses

Key Facts

1RF Industries (RFIL) reported Q2 earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09.

2Dave & Buster's (PLAY) reported Q1 earnings of $0.22 per share, missing the consensus estimate of $0.37.

3John Wiley & Sons (WLY) is projected to report Q4 results on June 16 with an EPS estimate of $1.65.

Amid shifting consumer confidence and operational cost pressures, the latest round of corporate reports revealed a divergent performance among US mid-cap stocks. RF Industries (RFIL) posted earnings of $0.14 per share, comfortably beating the $0.09 consensus estimate. Conversely, Dave & Buster's (PLAY) reported a miss, with earnings of $0.22 per share falling short of the anticipated $0.37, highlighting struggles within the consumer discretionary sector.

This divergence occurs as broader economic indicators suggest a cooling consumer environment, with the Westpac Consumer Confidence index dropping by 2.9% in June 2026 per market data. While industrial component providers like RFIL show resilience, entertainment-focused peers are grappling with persistent price pressures, as US CPI inflation reached 4.2% annually according to the latest June 10 data. These idiosyncratic results underscore the importance of selective positioning in the current macro climate.

Looking ahead, market attention shifts to John Wiley & Sons (WLY), which is projected to report Q4 results on June 16 with an EPS estimate of $1.65. Investors should also monitor upcoming retail sales data and industrial production figures to gauge the health of the broader economy. Volatility may persist in mid-cap names as smaller firms like NeuroSense Therapeutics and POWW prepare to release their respective financial updates.